Short- and Long-Term Effects of CDK4/6 Inhibition on Early-Stage Breast Cancer

William B Kietzman1, Garrett T Graham1, Virginie Ory1

  • 1Department of Oncology, Georgetown University, Washington, District of Columbia.

Insights

Palbociclib, a CDK4/6 inhibitor, prevents ductal carcinoma in situ progression and inhibits ER(-) invasive breast cancer growth, partly via MUC16. Lasting effects may influence early-stage treatment strategies.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Research

Background:

  • CDK4/6 inhibitors are established treatments for advanced ER(+) breast cancer.
  • Their role in ER(-) and early-stage breast cancer remains under investigation.

Purpose of the Study:

  • To investigate the efficacy of palbociclib, a CDK4/6 inhibitor, in both ER(-) and ER(+) breast cancer models, including ductal carcinoma in situ (DCIS) and invasive disease.
  • To explore the molecular mechanisms underlying palbociclib's effects, including gene expression changes and the role of MUC16.

Main Methods:

  • Utilized ER(-) (MCFDCIS) and ER(+) (MCF7) breast cancer models in vitro and in vivo.
  • Administered palbociclib and assessed tumor progression, proliferation, and senescence.
  • Performed transcriptomic analysis of tumor and stromal compartments.
  • Investigated the role of MUC16 through gene knockdown experiments.

Main Results:

  • Palbociclib inhibited DCIS progression and invasive disease growth in both ER(-) and ER(+) models.
  • Palbociclib repressed cell cycle genes, induced senescence, and normalized tumorspheres.
  • Transcriptomic analysis revealed repression of cell cycle, senescence genes, and MUC16.
  • MUC16 knockdown inhibited invasive lesion proliferation but not DCIS progression.
  • Post-treatment, differentiation and immune response genes remained suppressed.

Conclusions:

  • Palbociclib prevents DCIS progression and exhibits antiproliferative effects in ER(-) invasive breast cancer, partly mediated by MUC16.
  • Sustained effects on differentiation and immune response after drug withdrawal may impact early-stage ER(-) breast cancer treatment approaches.

Related Concept Videos

Feedback Inhibition00:46

Feedback Inhibition

Biochemical reactions are occurring constantly in cells, converting starting substances to different products, usually with the help of enzymes that speed the reactions. Without enzymes, it would take far too long for most reactions to occur to be useful to the cell!
56.9K
Long-term Depression01:05

Long-term Depression

Long-term depression, or LTD, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTD is the process of synaptic weakening that occurs over time between pre and postsynaptic neuronal connections. The synaptic weakening of LTD works in opposition to synaptic strengthening by long-term potentiation (LTP) and together are the main mechanisms that underlie learning and memory.
33.2K
Buffer Effectiveness02:19

Buffer Effectiveness

Buffer solutions do not have an unlimited capacity to keep the pH relatively constant . Instead, the ability of a buffer solution to resist changes in pH relies on the presence of appreciable amounts of its conjugate weak acid-base pair. When enough strong acid or base is added to substantially lower the concentration of either member of the buffer pair, the buffering action within the solution is compromised.
The buffer capacity is the amount of acid or base that can be added to a given volume...
54.9K
Framing Effects03:26

Framing Effects

Information is everywhere and its presentation—such as how and when items are presented—can impact our perceptions and decisions surrounding the info. This broad concept umbrellas framing effects—influences that occur due to the way information is framed in its appearance, whether it’s purely the order or the specific wording of a message. Let’s take a look at numerous ways in which two versions of something can objectively say the same thing, yet we respond in...
7.9K
Enzyme Inhibition01:30

Enzyme Inhibition

Inhibitors are molecules that reduce enzyme activity by binding to the enzyme. In a normally functioning cell, enzymes are regulated by a variety of inhibitors. Drugs and other toxins can also inhibit enzymes. Some inhibitors bind to the enzyme’s active site, while others inhibit enzymatic activity by binding to other sites on the protein structure.
91.7K
Biological Effects of Radiation02:59

Biological Effects of Radiation

All radioactive nuclides emit high-energy particles or electromagnetic waves. When this radiation encounters living cells, it can cause heating, break chemical bonds, or ionize molecules. The most serious biological damage results when these radioactive emissions fragment or ionize molecules. For example, α and β particles emitted from nuclear decay reactions possess much higher energies than ordinary chemical bond energies. When these particles strike and penetrate matter, they...
17.7K